What happened, in summary

Melissa Berry was 42 when routine high-risk screening found Stage I triple-negative breast cancer. Breast cancer ran strongly on her mother’s side, and Melissa had learned she carried a BRCA mutation. Because of that, she was being followed closely with MRI, mammogram, and ultrasound about every 6 months. She had recently had a clean MRI and expected her mammogram to be routine. Before the mammogram, a clinician felt a tiny lump in the left breast. Initial imaging did not clearly show cancer, but the head of the cancer center saw a shadow and insisted on a deep needle biopsy. That biopsy found a cancerous tumor. Because the tumor appeared quickly, her oncologist suspected triple-negative disease, later confirmed. Melissa had surgery first: a bilateral mastectomy with reconstruction using expanders and later implants. She had no lymph-node involvement, which supported the Stage I diagnosis. Chemotherapy followed; the video description says she completed 12 cycles, and Melissa describes receiving a Red Devil-type chemotherapy, though the exact full regimen is not specified. She focused on taking treatment one step at a time and managing the emotional weight of surgery and chemotherapy. As of July 2023, Melissa was a 10-year triple-negative breast cancer survivor with no recurrence reported, and she was using advocacy work to help others navigate diagnosis and survivorship.